Replimune Group, Inc. (REPL) Stock Analysis

Free AI-powered analysis and research for Replimune Group, Inc. stock

Sector: Healthcare

Analyze Replimune Group, Inc. (REPL) Stock

Replimune Group, Inc. (REPL) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into REPL stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Replimune Group, Inc. stock.

📰 Latest Update

Replimune Plans Layoffs After FDA Rejects Cancer Therapy. The Stock Hits an All-Time Low.

Mon, April 13, 2026 at 5:57 PM UTC 4 min read

Replimune announced plans for layoffs following the FDA's rejection of its cancer therapy, leading the stock to hit an all-time low. This development raises concerns for investors about the company's future prospects and its ability to recover from this setback. The rejection not only impacts Replimune's pipeline but also signals potential challenges in gaining regulatory approval for its therapies, which could affect investor confidence moving forward.

Read full article →

Why Analyze Replimune Group, Inc. (REPL) with StockIQ?

• ✅ Free AI-powered analysis of Replimune Group, Inc. (REPL) stock
• ✅ Real-time technical indicators for Replimune Group, Inc. stock
• ✅ Comprehensive risk assessment for REPL
• ✅ No credit card required

People also watch